Cosyntropin and Agranulocytosis - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Cosyntropin?
Cosyntropin has active ingredients of cosyntropin. Currently, eHealthMe is studying from 206 Cosyntropin users.
What is Agranulocytosis?
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 3,346 drugs and 3,460 conditions by eHealthMe. Currently, we are studying 199,061 people who have Agranulocytosis.
Do you take Cosyntropin and have Agranulocytosis?Check whether Agranulocytosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Cosyntropin side effects by duration, gender and age:
- Cosyntropin side effects (206 reports)
Agranulocytosis treatments and more:
- Agranulocytosis (199,061 reports)
All the drugs that are associated with Agranulocytosis:
All the conditions that are associated with Agranulocytosis:
How the study uses the data?
The study uses data from the FDA. It is based on cosyntropin (the active ingredients of Cosyntropin) and Cosyntropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methylcobalamin and Maxipime drug interaction - 12 seconds ago
- Imbruvica and Seizures - 21 seconds ago
- Altace and Arthritis - 23 seconds ago
- Tarceva and Xanax drug interaction - 25 seconds ago
- Lisinopril and Malignant Transformation - 30 seconds ago
- Lidocaine and Ischaemic Cardiomyopathy - 38 seconds ago
- Cephalexin and Abdominal Discomfort - 40 seconds ago
- Enbrel and Canagliflozin drug interaction - 42 seconds ago
- Vitamins and Respiratory Tract Infection Bacterial - 48 seconds ago
- Risperdal and Antisocial Behavior - 56 seconds ago